257 related articles for article (PubMed ID: 30207489)
21. Mastocytosis.
Abid A; Malone MA; Curci K
Prim Care; 2016 Sep; 43(3):505-18. PubMed ID: 27545739
[TBL] [Abstract][Full Text] [Related]
22. Detection of KIT D816V mutation in patients with severe anaphylaxis and normal basal tryptase-first data from the Anaphylaxis Registry (NORA).
Dölle-Bierke S; Siebenhaar F; Burmeister T; Worm M
J Allergy Clin Immunol; 2019 Nov; 144(5):1448-1450.e1. PubMed ID: 31415784
[No Abstract] [Full Text] [Related]
23. Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.
Jawhar M; Schwaab J; Horny HP; Sotlar K; Naumann N; Fabarius A; Valent P; Cross NC; Hofmann WK; Metzgeroth G; Reiter A
Eur J Clin Invest; 2016 May; 46(5):392-7. PubMed ID: 26914980
[TBL] [Abstract][Full Text] [Related]
24. An Unusual Transition from Cutaneous to Systemic Mastocytosis in a Pediatric Patient.
Patel K; Cuervo-Pardo L; Cresoe S; Cavero-Chavez V
Pediatr Allergy Immunol Pulmonol; 2023 Dec; 36(4):150-152. PubMed ID: 38134319
[No Abstract] [Full Text] [Related]
25. The impact of sensitive KIT D816V detection on recognition of indolent Systemic Mastocytosis.
De Matteis G; Zanotti R; Colarossi S; De Benedittis C; Garcia-Montero A; Bonifacio M; Sartori M; Aprili F; Caruso B; Paviati E; Carli G; Perbellini O; Zamò A; Bonadonna P; Pizzolo G; Guidi G; Martinelli G; Soverini S
Leuk Res; 2015 Mar; 39(3):273-8. PubMed ID: 25582384
[TBL] [Abstract][Full Text] [Related]
26. Validation of dermatopathological criteria to diagnose cutaneous lesions of mastocytosis: importance of KIT D816V mutation analysis.
Gebhard J; Horny HP; Kristensen T; Broesby-Olsen S; Zink A; Biedermann T; Brockow K
J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):1367-1375. PubMed ID: 35412687
[TBL] [Abstract][Full Text] [Related]
27. Coexistence of three variants of cutaneous mastocytosis as the presenting sign of systemic mastocytosis with somatic c-kit D816V point mutation.
Lesnoni La Parola I; Cannistraci C; Izzi S; Pisani F; Amantea A; Rongioletti F
Int J Dermatol; 2014 Oct; 53(10):1265-8. PubMed ID: 24738598
[No Abstract] [Full Text] [Related]
28. Role of imatinib in the treatment of pediatric onset indolent systemic mastocytosis: a case report.
Agarwala MK; George R; Mathews V; Balasubramanian P; Thomas M; Nair S
J Dermatolog Treat; 2013 Dec; 24(6):481-3. PubMed ID: 23659595
[TBL] [Abstract][Full Text] [Related]
29. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes.
Florian S; Krauth MT; Simonitsch-Klupp I; Sperr WR; Fritsche-Polanz R; Sonneck K; Födinger M; Agis H; Böhm A; Wimazal F; Horny HP; Valent P
Int Arch Allergy Immunol; 2005 Mar; 136(3):273-80. PubMed ID: 15722637
[TBL] [Abstract][Full Text] [Related]
30. Familial occurrence of systemic and cutaneous mastocytosis in an adult multicentre series.
Tanasi I; Bonifacio M; Pizzolato M; Irene Grifoni F; Sciumè M; Elena C; Benvenuti P; Mannelli F; Parente R; Schena D; Scaffidi L; Bonadonna P; Papayannidis C; Rondoni M; Criscuolo M; Vannucchi AM; Triggiani M; Martinelli G; Krampera M; Zanotti R
Br J Haematol; 2021 May; 193(4):845-848. PubMed ID: 33754335
[No Abstract] [Full Text] [Related]
31. [Cutaneous mastocytosis].
Flageul B
Rev Prat; 2006 Oct; 56(16):1745-51. PubMed ID: 17315498
[TBL] [Abstract][Full Text] [Related]
32. [An infant with macules and papules].
van der Waa JD; Vredenborg AD
Ned Tijdschr Geneeskd; 2020 Aug; 164():. PubMed ID: 32940988
[TBL] [Abstract][Full Text] [Related]
33. [Hypereosinophilia as the leading symptom in a patient with mastocytosis].
Musch E; Parwaresch R; Malek M; Chrissafidou A
Med Klin (Munich); 2005 May; 100(5):286-7. PubMed ID: 15902384
[No Abstract] [Full Text] [Related]
34. The Prevalence Of Osteoporosis Is Low in Adult Cutaneous Mastocytosis Patients.
Degboé Y; Severino-Freire M; Couture G; Apoil PA; Gaudenzio N; Hermine O; Ruyssen-Witrand A; Paul C; Laroche M; Constantin A; Livideanu CB
J Allergy Clin Immunol Pract; 2024 May; 12(5):1306-1312. PubMed ID: 38423295
[TBL] [Abstract][Full Text] [Related]
35. Morphologically occult systemic mastocytosis in bone marrow: clinicopathologic features and an algorithmic approach to diagnosis.
Reichard KK; Chen D; Pardanani A; McClure RF; Howard MT; Kurtin PJ; Wood AJ; Ketterling RP; King RL; He R; Morice WG; Hanson CA
Am J Clin Pathol; 2015 Sep; 144(3):493-502. PubMed ID: 26276780
[TBL] [Abstract][Full Text] [Related]
36. Prospective evaluation of the diagnostic value of sensitive KIT D816V mutation analysis of blood in adults with suspected systemic mastocytosis.
Kristensen T; Vestergaard H; Bindslev-Jensen C; Mortz CG; Kjaer HF; Ollert M; Møller MB; Broesby-Olsen S;
Allergy; 2017 Nov; 72(11):1737-1743. PubMed ID: 28432683
[TBL] [Abstract][Full Text] [Related]
37. [IgE mediated anaphylaxis in a patient with systemic mastocytosis].
Escande H; Bennani I; Bulai Livideanu C; Uthurriague C; Paul C; Nougué J
Ann Dermatol Venereol; 2013 Oct; 140(10):641-4. PubMed ID: 24090896
[TBL] [Abstract][Full Text] [Related]
38. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
Divekar R; Butterfield J
Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
[TBL] [Abstract][Full Text] [Related]
39. Childhood mastocytosis.
Torrelo A; Alvarez-Twose I; Escribano L
Curr Opin Pediatr; 2012 Aug; 24(4):480-6. PubMed ID: 22790101
[TBL] [Abstract][Full Text] [Related]
40. The genetic basis of mast cell activation disease - looking through a glass darkly.
Molderings GJ
Crit Rev Oncol Hematol; 2015 Feb; 93(2):75-89. PubMed ID: 25305106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
